Oryzon Genomics S.A. (BME:ORY)
Spain
· Delayed Price · Currency is EUR 2.630
+0.005 (0.19%)
Aug 15, 2025, 5:35 PM CET
Oryzon Genomics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -4.22 | -3.67 | -3.35 | -4.23 | -4.69 | -3.4 | Upgrade
|
| Depreciation & Amortization | 0.11 | 0.13 | 0.13 | 0.15 | 0.13 | 0.13 | Upgrade
|
| Other Amortization | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0 | 0 | Upgrade
|
| Other Operating Activities | 1.13 | -1.11 | 3.39 | 0.96 | -1.22 | -0.34 | Upgrade
|
| Change in Accounts Receivable | -0.04 | 0.01 | 0.34 | 0.29 | -0.11 | 0.16 | Upgrade
|
| Change in Inventory | 0 | 0 | 0 | 0.09 | 0.21 | -0.03 | Upgrade
|
| Change in Accounts Payable | -0.92 | -0.92 | -1.13 | 0.87 | 1.21 | -1.37 | Upgrade
|
| Change in Other Net Operating Assets | 0.88 | -0.16 | 0.03 | 0 | 0.82 | 0.02 | Upgrade
|
| Operating Cash Flow | -3.03 | -5.69 | -0.57 | -1.85 | -3.63 | -4.82 | Upgrade
|
| Capital Expenditures | - | - | - | -0.08 | -0.18 | -0.15 | Upgrade
|
| Sale (Purchase) of Intangibles | -7.55 | -7.71 | -14.5 | -14.2 | -11.59 | -9.07 | Upgrade
|
| Other Investing Activities | -0.1 | -0.1 | -0 | -0 | 0.04 | 0.14 | Upgrade
|
| Investing Cash Flow | -7.65 | -7.81 | -14.5 | -14.27 | -11.72 | -9.08 | Upgrade
|
| Short-Term Debt Issued | - | 7 | 13.77 | 8.95 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 6.53 | 1.74 | 5.11 | 7.96 | 7.07 | Upgrade
|
| Total Debt Issued | 9.31 | 13.53 | 15.51 | 14.07 | 7.96 | 7.07 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.81 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -8.15 | -6.8 | -4.43 | -3.84 | -6.87 | Upgrade
|
| Total Debt Repaid | -6.91 | -8.15 | -7.61 | -4.43 | -3.84 | -6.87 | Upgrade
|
| Net Debt Issued (Repaid) | 2.4 | 5.37 | 7.9 | 9.64 | 4.12 | 0.2 | Upgrade
|
| Issuance of Common Stock | 28.75 | 0.07 | - | - | - | 17.96 | Upgrade
|
| Repurchase of Common Stock | - | - | -1.8 | -1 | - | - | Upgrade
|
| Other Financing Activities | 0.56 | 1.43 | -0.08 | 0.07 | - | 0.23 | Upgrade
|
| Financing Cash Flow | 31.71 | 6.87 | 6.02 | 8.71 | 4.12 | 18.38 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | -0.01 | -0 | 0 | 0.35 | 0.01 | Upgrade
|
| Net Cash Flow | 21.04 | -6.64 | -9.06 | -7.41 | -10.88 | 4.49 | Upgrade
|
| Free Cash Flow | -3.03 | -5.69 | -0.57 | -1.92 | -3.8 | -4.97 | Upgrade
|
| Free Cash Flow Margin | -40.53% | -77.32% | -4.05% | -12.25% | -35.82% | -52.20% | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.09 | -0.01 | -0.04 | -0.07 | -0.09 | Upgrade
|
| Cash Interest Paid | 0.33 | 0.38 | 0.4 | 0.32 | 0.26 | 0.25 | Upgrade
|
| Cash Income Tax Paid | - | - | -4.67 | -2.48 | -1.3 | -0.86 | Upgrade
|
| Levered Free Cash Flow | -10.22 | -13.75 | -18.62 | -16.17 | -15.73 | -13.5 | Upgrade
|
| Unlevered Free Cash Flow | -9.57 | -12.98 | -17.44 | -15.47 | -15.44 | -13.21 | Upgrade
|
| Change in Working Capital | -0.08 | -1.07 | -0.76 | 1.26 | 2.13 | -1.22 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.